Real-world data on neoadjuvant chemotherapy with dual-anti HER2 therapy in HER2 positive breast cancer. Yang ZJ, Xin F, Chen ZJ, Yu Y, et al. BMC Cancer 2024;24:134.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang ZJ, Xin F, Chen ZJ, Yu Y, et al. Real-world data on neoadjuvant chemotherapy with dual-anti HER2 therapy in HER2 positive breast cancer. BMC Cancer 2024;24:134.
PMID: 38273267